Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Larue, A. Fontaine, S. Colleau (1997)
Underestimation and undertreatment of pain in HIV disease: multicentre studyBMJ, 314
L. Campbell-Sills, S. Norman, M. Craske, G. Sullivan, A. Lang, D. Chavira, A. Bystritsky, C. Sherbourne, P. Roy-Byrne, M. Stein (2009)
Validation of a brief measure of anxiety-related severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS).Journal of affective disorders, 112 1-3
R. Bruce, J. Merlin, Paula Lum, Ebtesam Ahmed, C. Alexander, A. Corbett, K. Foley, K. Leonard, G. Treisman, P. Selwyn (2017)
2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 65 10
A. Justice, W. Holmes, A. Gifford, L. Rabeneck, R. Zackin, G. Sinclair, S. Weissman, J. Neidig, C. Marcus, M. Chesney, S. Cohn, A. Wu (2001)
Development and validation of a self-completed HIV symptom index.Journal of clinical epidemiology, 54 Suppl 1
R. Saitz, Aldina Mesic, A. Ventura, M. Winter, T. Heeren, M. Sullivan, A. Walley, G. Patts, S. Meli, M. Holick, Theresa Kim, K. Bryant, J. Samet (2018)
Alcohol Consumption and Bone Mineral Density in People with HIV and Substance Use Disorder: A Prospective Cohort StudyAlcoholism: Clinical and Experimental Research, 42
A. Selim, W. Rogers, J. Fleishman, S. Qian, B. Fincke, J. Rothendler, L. Kazis (2009)
Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12)Quality of Life Research, 18
J. Merlin, Dustin Long, W. Becker, E. Cachay, K. Christopoulos, Kasey Claborn, H. Crane, E. Edelman, R. Harding, S. Kertesz, J. Liebschutz, W. Mathews, M. Mugavero, S. Napravnik, Connall O'Cleirigh, M. Saag, Joanna Starrels, R. Gross (2018)
Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment OutcomesJAIDS Journal of Acquired Immune Deficiency Syndromes, 79
Amanda Fairchild, D. Mackinnon (2009)
A General Model for Testing Mediation and Moderation EffectsPrevention Science, 10
G. Campbell, W. Hall, A. Peacock, N. Lintzeris, R. Bruno, B. Larance, S. Nielsen, Milton Cohen, Gary Chan, R. Mattick, F. Blyth, M. Shanahan, T. Dobbins, M. Farrell, L. Degenhardt (2018)
Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.The Lancet. Public health, 3 7
T. Atkinson, B. Rosenfeld, L. Sit, T. Mendoza, M. Fruscione, D. Lavene, Mary Shaw, Yuelin Li, J. Hay, C. Cleeland, H. Scher, W. Breitbart, E. Basch (2011)
Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI).Journal of pain and symptom management, 41 3
Emily Woolridge, S. Barton, J. Samuel, J. Osório, A. Dougherty, A. Holdcroft (2005)
Cannabis use in HIV for pain and other medical symptoms.Journal of pain and symptom management, 29 4
B. Hartzler, Julia Dombrowski, H. Crane, J. Eron, E. Geng, W. Mathews, K. Mayer, R. Moore, M. Mugavero, S. Napravnik, B. Rodriguez, D. Donovan (2017)
Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United StatesAIDS and Behavior, 21
D. Abrams, C. Jay, S. Shade, H. Vizoso, Haatem Reda, S. Press, M. Kelly, M. Rowbotham, K. Petersen (2007)
Cannabis in painful HIV-associated sensory neuropathyNeurology, 68
E. Groce (2018)
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for ResearchJournal of Medical Regulation
A. Mclellan, H. Kushner, D. Metzger, R. Peters, Iris Smith, G. Grissom, H. Pettinati, M. Argeriou (1992)
The Fifth Edition of the Addiction Severity Index.Journal of substance abuse treatment, 9 3
C. Shover, C. Davis, S. Gordon, K. Humphreys (2019)
Association between medical cannabis laws and opioid overdose mortality has reversed over timeProceedings of the National Academy of Sciences of the United States of America, 116
C. Miaskowski, J. Penko, D. Guzman, Jennifer Mattson, D. Bangsberg, M. Kushel (2011)
Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection.The journal of pain : official journal of the American Pain Society, 12 9
Theresa Kim, A. Walley, T. Heeren, G. Patts, A. Ventura, Gabriel Lerner, Nicholas Mauricio, R. Saitz (2017)
Polypharmacy and risk of non-fatal overdose for patients with HIV infection and substance dependence.Journal of substance abuse treatment, 81
D. Sheehan, Y. Lecrubier, K. Sheehan, P. Amorim, J. Janavs, E. Weiller, T. Hergueta, Roxy Baker, G. Dunbar (1998)
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.The Journal of clinical psychiatry, 59 Suppl 20
E. Stockings, G. Campbell, W. Hall, S. Nielsen, Dino Zagic, R. Rahman, B. Murnion, M. Farrell, Megan Weier, L. Degenhardt (2018)
Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studiesPAIN, 159
J. Fleet, S. Dixon, Paul Kuwornu, Varun Dev, M. Montero‐Odasso, J. Burneo, A. Garg (2018)
Gabapentin dose and the 30-day risk of altered mental status in older adults: A retrospective population-based studyPLoS ONE, 13
D. Ghosh (2019)
Cannabis and CannabinoidsNatural Medicines
K. Hill (2019)
Medical Use of Cannabis in 2019.JAMA
New York State Department of Health Announces Opioid Replacement Now a Qualifying Condition for
J. Tsui, D. Cheng, S. Coleman, M. Lira, E. Blokhina, C. Bridden, E. Krupitsky, J. Samet (2014)
Pain is associated with risky drinking over time among HIV-infected persons in St. Petersburg, Russia.Drug and alcohol dependence, 144
Ronald Ellis, Will Toperoff, F. Vaida, G. Brande, J. Gonzales, B. Gouaux, Heather Bentley, J Atkinson (2009)
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical TrialNeuropsychopharmacology, 34
G. Tan, M. Jensen, J. Thornby, B. Shanti (2004)
Validation of the Brief Pain Inventory for chronic nonmalignant pain.The journal of pain : official journal of the American Pain Society, 5 2
W. Tormey (2010)
Adverse health effects of non-medical cannabis useThe Lancet, 375
(2007)
Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial, 68
Luca Eibach, S. Scheffel, Madeleine Cardebring, M. Lettau, M. Celik, A. Morguet, R. Roehle, C. Stein (2020)
Cannabidivarin for HIV‐Associated Neuropathic Pain: A Randomized, Blinded, Controlled Clinical TrialClinical Pharmacology & Therapeutics, 109
L. Valeri, T. VanderWeele (2013)
Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros.Psychological methods, 18 2
Javier Martínez-Calderon, Mar Flores-Cortes, Susana Clavero-Cano, J. Morales‐Asencio, M. Jensen, Antonio Rondon-Ramos, Juan Díaz-Cerrillo, Gina Ariza-Hurtado, A. Luque-Suarez (2020)
The Role of Positive Psychological Factors in the Association between Pain Intensity and Pain Interference in Individuals with Chronic Musculoskeletal Pain: A Cross-Sectional StudyJournal of Clinical Medicine, 9
Dylan Addis, J. DeBerry, S. Aggarwal (2020)
Chronic Pain in HIVMolecular Pain, 16
W. Becker, Yu Li, E. Caniglia, Rachel Vickers-Smith, T. Feinberg, Brandon Marshall, E. Edelman (2021)
Cannabis use, pain interference, and prescription opioid receipt among persons with HIV: a target trial emulation studyAIDS Care, 34
(2001)
Adult AIDS clinical trials unit outcomes committee. Development and validation of a self-completed HIV symptom index, 54
Cannabis is often used by people with HIV (PWH) for pain, yet study results are inconsistent regarding whether and how it affects pain. This study examines whether greater cannabis use frequency is associated with lower pain interference and whether cannabis use modifies the association of pain severity and pain interference among 134 PWH with substance dependence or a lifetime history of injection drug use. Multi-variable linear regression models examined the association between past 30-day cannabis use frequency and pain interference. Additional models evaluated whether cannabis use modified the association between pain severity and pain interference. Cannabis use frequency was not significantly associated with pain interference. However, in a model with interaction between cannabis use frequency and pain severity, greater cannabis use frequency attenuated the strength of the association between pain severity and pain interference (p = 0.049). The adjusted mean difference (AMD) in pain interference was +1.13, + 0.81, and +0.05 points for each 1-point increase in pain severity for those with no cannabis use, 15 days of use, and daily use, respectively. These findings suggest that attenuating the impact of pain severity on pain-related functional impairment is a potential mechanism for a beneficial role of cannabis for PWH.
AIDS Care – Taylor & Francis
Published: Aug 3, 2023
Keywords: HIV; AIDS; pain; cannabis; marijuana; opioid
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.